Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NicoBloc vs Nicotine Lozenges for Smoking Cessation
NCT03720899Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nicotine dependence (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Treatment Satisfaction Survey at 4 months. Started Mar 2019; status: completed.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03720899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03720899.